FDA Approves Generic Medication for Muscle Relaxation, Tracheal Intubation

Article

The new product is therapeutically equivalent to Pfizer’s Quelicin.

Amphastar Pharmaceuticals has received FDA approval for succinylcholine chloride injection USP, 200 mg/10mL multiple-dose vials as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

The new product is therapeutically equivalent to Pfizer’s Quelicin. According to Amphastar, IQVIA data showed that succinylocholine chloride injection USP, 200 mg/10 mL made approximately $75 million in United States market annual sales for the 12 months prior to March 31, 2020.

REFERENCE

Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) Multiple-Dose Vial [news release]. Amphastar Pharmaceuticals; June 9, 2020. http://ir.amphastar.com/news-releases/news-release-details/amphastar-pharmaceuticals-inc-receives-fda-approval. Accessed June 9, 2020.

Related Videos
pharmacy oncology, Image Credit: © Konstantin Yuganov - stock.adobe.com
Mayo Clinic oncology pharmacy
Testicular cancer and prostate cancer concept. | Image Credit: kenchiro168 - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Bottle and scattered pills on color background, top view | Image Credit: New Africa - stock.adobe.com
pharmacy | Image Credit: Diego Cervo - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.